×

R&D For Your Portfolio: 3 Stocks in 3 Sectors

7:44 AM ET Wed, 17 April 2013

Mark Lehmann, JMP Securities president, provides investment strategies that include a biotech company with a promising drug to fight a rare form of Leukemia.